MYCN and neoplasm: Observations made with BET inhibitors JQ1 or OTX015 targeting both c-MYC and MYCN warrant additional studies using MYCN specific inhibition such as HUWE1 inhibitors or specific knockdown to differentiate the relative importance of c-MYC and MYCN in ATL tumor cells survival and proliferation.